Her litigation practice focuses on complex securities matters, financial regulatory enforcement actions, and internal investigations. Recently, she has represented:
Louis Dreyfus Company in an ongoing commodities class action litigation;
A publicly traded pharmaceutical company in ongoing government investigations; and
A Fortune 50 company in ongoing shareholder demand disputes.
Sloan was also recently published in The American Criminal Law Review for her note, “The Need for a Clear Statement After 'Bridgegate': Combatting SCOTUS’s Narrowing View of Corruption with an 'Abuse of Functions' Offense."
Kelsey, based in the New York Office, works closely with innovative startups and venture capital investors, helping them navigate the legal complexities of growing their business. Focusing on venture capital financings, mergers and acquisitions, and corporate governance, Kelsey enjoys guiding clients from the early stages of their journey through to successful exits.
He advises clients on intellectual property law, in particular in the context of IP license or assignment agreements, R&D collaborations, mergers and acquisitions or venture and other strategic transactions that involve the commercialization of IP.
Simon also advises clients on strategic IP protection and enforcement, in particular in the field of patent, trademark and copyright law.
Prior to joining Orrick, Simon was a trainee lawyer with three renown international law firms as well as with the German Federal Cartel Office.
Christine has more than two decades of experience in public infrastructure finance, advising on both traditional bond financings and innovative funding structures. She serves as a Vice-Chair of the Public Finance Group and on the leadership team for the Impact Finance Group.
Christine’s experience includes various general obligation and revenue bond financings, including those relating to transportation, education, healthcare, water and wastewater, economic development, urban renewal, public power and other complex and innovative social and infrastructure financings sometimes involving public-private partnerships (P3) for large transportation and utility issuers, state and local municipalities, and other for-profit and nonprofit corporations.
She has extensive knowledge and experience with disclosure requirements for municipal issuers under federal securities laws, including both initial and continuing disclosure issues, material events disclosure, public offerings, private placements and other municipal securities regulatory matters.
Christine is a frequent speaker at conferences and seminars given by trade and professional organizations within the municipal finance industry, including serving as Chair for The Bond Buyer's 2022 Infrastructure Conference and Board of Directors to Women in Public Finance.
He currently is national coordinating counsel for a major
oil company in connection with its climate change litigation. He previously
served as co-lead counsel to a major international pharmaceutical manufacturer
in the defense of nationwide litigation challenging industry pricing practices.
Rob’s experience includes extensive work in antitrust and
False Claims Act cases, claims alleging fraud, and agency enforcement actions. His
pharmaceutical industry activities include service as outside counsel to and Corporate
Secretary of the Pharmaceutical Security Institute, Inc., the industry’s
not-for-profit trade organization dedicated to the fight against pharmaceutical
counterfeiting.
He is Managing Editor of The
World in U.S. Courts, Orrick’s quarterly review of court decisions
addressing personal jurisdiction over non-U.S. parties and the extraterritorial
application of U.S. law to global business and cross-border activities.
Rob also served two terms on the District of Columbia Bar’s Pro
Bono standing committee. Before
joining Orrick, he was a partner in Hughes Hubbard & Reed LLP and Clifford
& Warnke, in Washington, D.C.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.